Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Significant Growth in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUTGet Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 812 shares, an increase of 7,281.8% from the June 15th total of 11 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 3,083 shares, the days-to-cover ratio is currently 0.3 days.

Innovator IBD Breakout Opportunities ETF Trading Down 0.7%

Shares of Innovator IBD Breakout Opportunities ETF stock traded down $0.35 during trading hours on Friday, hitting $46.66. 1,926 shares of the company were exchanged, compared to its average volume of 4,263. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $49.41. The business has a 50-day moving average of $46.84 and a 200-day moving average of $42.25. The stock has a market capitalization of $16.33 million, a price-to-earnings ratio of 28.69 and a beta of 1.03.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Osaic Holdings Inc. raised its position in Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after acquiring an additional 597 shares in the last quarter. Comprehensive Wealth Management LLC boosted its position in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares in the last quarter. Finally, Susquehanna International Group LLP boosted its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Company Profile

(Get Free Report)

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.

Read More

Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.